Last 12 months
Inside the activity.
0 purchase rows · 12 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2021 Filed Jun 2, 2021 20:34 UTC |
Majors Cary LSr VP N America Com Operations
|
Disposition to issuerOrdinary Shares | 2,129 | $188.43 | $401,167.47 |
DisclosureSEC source: 0001209191-21-037206 · doc4.xml · nonDerivative · entry 1 Majors Cary L · CIK 0001776271 · Sr VP N America Com Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,991 F1 · shares: 2,129 shares were withheld from the 6,500 restricted shares that vested on June 1, 2021. These 2,129 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 6,500 ordinary shares were awarded to Mr. Majors on May 30, 2017. These vested shares were valued at the NYSE closing market price on June 1, 2021. F2 · balance_after: 7,120 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,520 on May 31, 2022; 2,224 on May 31, 2023 and 2,367 on June 3, 2024. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 20:33 UTC |
Zangerle John AdamSr. VP, Gen Counsel, and Sec.
|
Disposition to issuerOrdinary Shares | 1,945 | $188.43 | $366,496.35 |
DisclosureSEC source: 0001209191-21-037201 · doc4.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,939 F1 · shares: 1,945 shares were withheld from the 6,000 restricted shares that vested on June 1, 2021. These 1,945 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 6,000 ordinary shares were awarded to Mr. Zangerle on May 30, 2017. These vested shares were valued at the NYSE closing market price on June 1, 2021. F2 · balance_after: 9,980 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,636 on May 31, 2022; 2,502 on May 31, 2022; 1,504 on June 1, 2022; 834 on May 31, 2023; 752 on June 1, 2023 and 752 on June 3, 2024. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 20:31 UTC |
Carestio Daniel ASr VP and Chief Operating Off
|
Disposition to issuerOrdinary Shares | 1,677 | $188.43 | $315,997.11 |
DisclosureSEC source: 0001209191-21-037194 · doc4.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,637 F1 · shares: 1,677 shares were withheld from the 5,500 restricted shares that vested on June 1, 2021. These 1,677 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 5,500 ordinary shares were awarded to Mr. Carestio on May 30, 2017. These vested shares were valued at the NYSE closing market price on June 1, 2021. F2 · balance_after: 13,900 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,712 on May 31, 2022; 1,748 on October 3, 2022; 5,008 on May 31, 2023; 3,324 on June 1, 2023 and 1,108 on June 3, 2024. Read SEC document |
| May 27, 2021 Filed May 27, 2021 20:39 UTC |
Breeden Richard CDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,121 | $0.00 Strike: $31.61 | $0.00 |
DisclosureSEC source: 0001209191-21-036259 · doc4.xml · derivative · entry 3 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,121 shares Expires 2021-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option to purchase 3,121 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 3,121 Old STERIS ordinary shares for $31.61 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| May 27, 2021 Filed May 27, 2021 20:39 UTC |
Breeden Richard CDirector
|
Exercise / conversionOrdinary Shares | 3,121 | $31.61 | $98,654.81 |
DisclosureSEC source: 0001209191-21-036259 · doc4.xml · nonDerivative · entry 1 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,802 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 25, 2021 Filed May 26, 2021 20:35 UTC |
FELDMANN CYNTHIA LDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,890 | $0.00 Strike: $71.40 | $0.00 |
DisclosureSEC source: 0001209191-21-035936 · doc4.xml · derivative · entry 7 FELDMANN CYNTHIA L · CIK 0001264554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,891 Underlying: Ordinary Shares · 1,890 shares Expires 2026-08-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is part of an option to purchase 3,781 STERIS ordinary shares, which are fully vested, which was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 3,781 Old STERIS ordinary shares for $71.40 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| May 25, 2021 Filed May 26, 2021 20:35 UTC |
FELDMANN CYNTHIA LDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,110 | $0.00 Strike: $64.05 | $0.00 |
DisclosureSEC source: 0001209191-21-035936 · doc4.xml · derivative · entry 6 FELDMANN CYNTHIA L · CIK 0001264554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,110 shares Expires 2025-08-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option to purchase 2,110 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 2,110 Old STERIS ordinary shares for $64.05 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| May 25, 2021 Filed May 26, 2021 20:35 UTC |
FELDMANN CYNTHIA LDirector
|
SaleOrdinary Shares | 1,890 | $190.84 | $360,687.60 |
DisclosureSEC source: 0001209191-21-035936 · doc4.xml · nonDerivative · entry 4 FELDMANN CYNTHIA L · CIK 0001264554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 705 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $190.78 to $191.03 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 25, 2021 Filed May 26, 2021 20:35 UTC |
FELDMANN CYNTHIA LDirector
|
Exercise / conversionOrdinary Shares | 1,890 | $71.40 | $134,946.00 |
DisclosureSEC source: 0001209191-21-035936 · doc4.xml · nonDerivative · entry 3 FELDMANN CYNTHIA L · CIK 0001264554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,595 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 25, 2021 Filed May 26, 2021 20:35 UTC |
FELDMANN CYNTHIA LDirector
|
SaleOrdinary Shares | 2,110 | $190.84 | $402,672.40 |
DisclosureSEC source: 0001209191-21-035936 · doc4.xml · nonDerivative · entry 2 FELDMANN CYNTHIA L · CIK 0001264554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 705 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $190.78 to $191.03 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 25, 2021 Filed May 26, 2021 20:35 UTC |
FELDMANN CYNTHIA LDirector
|
Exercise / conversionOrdinary Shares | 2,110 | $64.05 | $135,145.50 |
DisclosureSEC source: 0001209191-21-035936 · doc4.xml · nonDerivative · entry 1 FELDMANN CYNTHIA L · CIK 0001264554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,815 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2021 Filed May 24, 2021 20:33 UTC |
KOSECOFF JACQUELINE BDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,121 | $0.00 Strike: $31.61 | $0.00 |
DisclosureSEC source: 0001209191-21-035332 · doc4.xml · derivative · entry 4 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,121 shares Expires 2021-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option to purchase 3,121 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 3,121 Old STERIS ordinary shares for $31.61 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| May 21, 2021 Filed May 24, 2021 20:33 UTC |
KOSECOFF JACQUELINE BDirector
|
SaleOrdinary Shares | 3,121 | $192.59 | $601,073.39 |
DisclosureSEC source: 0001209191-21-035332 · doc4.xml · nonDerivative · entry 2 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $192.92 to $193.025 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 21, 2021 Filed May 24, 2021 20:33 UTC |
KOSECOFF JACQUELINE BDirector
|
Exercise / conversionOrdinary Shares | 3,121 | $31.61 | $98,654.81 |
DisclosureSEC source: 0001209191-21-035332 · doc4.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,121 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 23, 2021 Filed Apr 26, 2021 20:36 UTC |
Madsen JuliaSenior VP, Life Sciences
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,000 | $0.00 Strike: $69.72 | $0.00 |
DisclosureSEC source: 0001209191-21-028282 · doc4.xml · derivative · entry 3 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400 Underlying: Ordinary Shares · 1,000 shares Expires 2026-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option to purchase 1,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 1,000 Old STERIS ordinary shares for $69.72 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| April 23, 2021 Filed Apr 26, 2021 20:36 UTC |
Madsen JuliaSenior VP, Life Sciences
|
SaleOrdinary Shares | 1,000 | $215.00 | $215,000.00 |
DisclosureSEC source: 0001209191-21-028282 · doc4.xml · nonDerivative · entry 2 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,641 F2 · shares: This exercise of stock options and sale of a total of 1,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on December 3, 2020. F1 · balance_after: 2,714 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 308 on June 1, 2021; 121 on June 1, 2021; 92 on June 1, 2021; 123 on June 1, 2021; 349 on October 1, 2021; 121 on May 31, 2022; 92 on May 31, 2022; 123 on June 1, 2022; 349 on October 3, 2022; 92 on May 31, 2023; 349 on October 2, 2023; 123 on June 1, 2023; 123 on June 3, 2024; and 349 on October 1, 2024. Read SEC document |
| April 23, 2021 Filed Apr 26, 2021 20:36 UTC |
Madsen JuliaSenior VP, Life Sciences
|
Exercise / conversionOrdinary Shares | 1,000 | $69.72 | $69,720.00 |
DisclosureSEC source: 0001209191-21-028282 · doc4.xml · nonDerivative · entry 1 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,641 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: 2,714 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 308 on June 1, 2021; 121 on June 1, 2021; 92 on June 1, 2021; 123 on June 1, 2021; 349 on October 1, 2021; 121 on May 31, 2022; 92 on May 31, 2022; 123 on June 1, 2022; 349 on October 3, 2022; 92 on May 31, 2023; 349 on October 2, 2023; 123 on June 1, 2023; 123 on June 3, 2024; and 349 on October 1, 2024. Read SEC document |
| April 20, 2021 Filed Apr 22, 2021 20:34 UTC |
Madsen JuliaSenior VP, Life Sciences
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,000 | $0.00 Strike: $69.72 | $0.00 |
DisclosureSEC source: 0001209191-21-027948 · doc4.xml · derivative · entry 3 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,400 Underlying: Ordinary Shares · 1,000 shares Expires 2026-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option to purchase 1,000 STERIS ordinary shares, which are fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 1,000 Old STERIS ordinary shares for $69.72 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| April 20, 2021 Filed Apr 22, 2021 20:34 UTC |
Madsen JuliaSenior VP, Life Sciences
|
SaleOrdinary Shares | 1,000 | $210.00 | $210,000.00 |
DisclosureSEC source: 0001209191-21-027948 · doc4.xml · nonDerivative · entry 2 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,641 F2 · shares: This exercise of stock options and sale of a total of 1,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on December 3, 2020. F1 · balance_after: 2,714 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 308 on June 1, 2021; 121 on June 1, 2021; 92 on June 1, 2021; 123 on June 1, 2021; 349 on October 1, 2021; 121 on May 31, 2022; 92 on May 31, 2022; 123 on June 1, 2022; 349 on October 3, 2022; 92 on May 31, 2023; 349 on October 2, 2023; 123 on June 1, 2023; 123 on June 3, 2024; and 349 on October 1, 2024. Read SEC document |
| April 20, 2021 Filed Apr 22, 2021 20:34 UTC |
Madsen JuliaSenior VP, Life Sciences
|
Exercise / conversionOrdinary Shares | 1,000 | $69.72 | $69,720.00 |
DisclosureSEC source: 0001209191-21-027948 · doc4.xml · nonDerivative · entry 1 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,641 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: 2,714 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 308 on June 1, 2021; 121 on June 1, 2021; 92 on June 1, 2021; 123 on June 1, 2021; 349 on October 1, 2021; 121 on May 31, 2022; 92 on May 31, 2022; 123 on June 1, 2022; 349 on October 3, 2022; 92 on May 31, 2023; 349 on October 2, 2023; 123 on June 1, 2023; 123 on June 3, 2024; and 349 on October 1, 2024. Read SEC document |
| January 08, 2021 Filed Jan 8, 2021 21:33 UTC |
Madsen JuliaSenior VP, Life Sciences
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 300 | $0.00 Strike: $69.72 | $0.00 |
DisclosureSEC source: 0001209191-21-002719 · doc4.xml · derivative · entry 5 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,400 Underlying: Ordinary Shares · 300 shares Expires 2026-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option to purchase 300 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 300 Old STERIS ordinary shares for $69.72 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| January 08, 2021 Filed Jan 8, 2021 21:33 UTC |
Madsen JuliaSenior VP, Life Sciences
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 700 | $0.00 Strike: $66.15 | $0.00 |
DisclosureSEC source: 0001209191-21-002719 · doc4.xml · derivative · entry 4 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 700 shares Expires 2025-05-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option to purchase 700 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 700 Old STERIS ordinary shares for $66.15 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| January 08, 2021 Filed Jan 8, 2021 21:33 UTC |
Madsen JuliaSenior VP, Life Sciences
|
SaleOrdinary Shares | 1,000 | $202.00 | $202,000.00 |
DisclosureSEC source: 0001209191-21-002719 · doc4.xml · nonDerivative · entry 3 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,641 F1 · shares: This exercise of stock options and sale of a total of 1,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on December 3, 2020. F2 · balance_after: 2,714 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 308 on June 1, 2021; 121 on June 1, 2021; 92 on June 1, 2021; 123 on June 1, 2021; 349 on October 1, 2021; 121 on May 31, 2022; 92 on May 31, 2022; 123 on June 1, 2022; 349 on October 3, 2022; 92 on May 31, 2023; 349 on October 2, 2023; 123 on June 1, 2023; 123 on June 3, 2024; and 349 on October 1, 2024. Read SEC document |
| January 08, 2021 Filed Jan 8, 2021 21:33 UTC |
Madsen JuliaSenior VP, Life Sciences
|
Exercise / conversionOrdinary Shares | 300 | $69.72 | $20,916.00 |
DisclosureSEC source: 0001209191-21-002719 · doc4.xml · nonDerivative · entry 2 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,641 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2021 Filed Jan 8, 2021 21:33 UTC |
Madsen JuliaSenior VP, Life Sciences
|
Exercise / conversionOrdinary Shares | 700 | $66.15 | $46,305.00 |
DisclosureSEC source: 0001209191-21-002719 · doc4.xml · nonDerivative · entry 1 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,341 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2020 Filed Dec 2, 2020 16:34 UTC |
LEWIS DAVID BDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,560 | $0.00 Strike: $31.61 | $0.00 |
DisclosureSEC source: 0001209191-20-061181 · doc4.xml · derivative · entry 3 LEWIS DAVID B · CIK 0001136554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,561 Underlying: Ordinary Shares · 1,560 shares Expires 2021-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is part of an option to purchase 3,121 STERIS ordinary shares, which is fully vested, which was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 3,121 Old STERIS ordinary shares for $31.61 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| December 01, 2020 Filed Dec 2, 2020 16:34 UTC |
LEWIS DAVID BDirector
|
SaleOrdinary Shares | 1,560 | $193.79 | $302,312.40 |
DisclosureSEC source: 0001209191-20-061181 · doc4.xml · nonDerivative · entry 2 LEWIS DAVID B · CIK 0001136554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,684 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $193.75 to $193.8033 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 01, 2020 Filed Dec 2, 2020 16:34 UTC |
LEWIS DAVID BDirector
|
Exercise / conversionOrdinary Shares | 1,560 | $31.61 | $49,311.60 |
DisclosureSEC source: 0001209191-20-061181 · doc4.xml · nonDerivative · entry 1 LEWIS DAVID B · CIK 0001136554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,244 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 30, 2020 Filed Dec 1, 2020 21:33 UTC |
KOSECOFF JACQUELINE BDirector
|
GiftOrdinary Shares | 7,644 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-060897 · doc4.xml · nonDerivative · entry 2 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below Disclosed balance after: 26,639 F2 · balance_after: 784 ordinary shares previously reported and held individually by the Reporting Person were transferred to a revocable family trust of the Reporting Person and the Reporting Person's spouse, as Co-Trustees. F1 · ownership.nature: These ordinary shares are held in a revocable family trust of the Reporting Person and the Reporting Person's spouse, as Co-Trustees. Read SEC document |
| November 30, 2020 Filed Dec 1, 2020 21:33 UTC |
KOSECOFF JACQUELINE BDirector
|
GiftOrdinary Shares | 10,286 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-060897 · doc4.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below Disclosed balance after: 34,283 F1 · ownership.nature: These ordinary shares are held in a revocable family trust of the Reporting Person and the Reporting Person's spouse, as Co-Trustees. Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 21:33 UTC |
Madsen JuliaSenior VP, Life Sciences
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 800 | $0.00 Strike: $53.52 | $0.00 |
DisclosureSEC source: 0001209191-20-057653 · doc4.xml · derivative · entry 6 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 800 shares Expires 2024-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option to purchase 800 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 800 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 21:33 UTC |
Madsen JuliaSenior VP, Life Sciences
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,100 | $0.00 Strike: $45.34 | $0.00 |
DisclosureSEC source: 0001209191-20-057653 · doc4.xml · derivative · entry 5 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,100 shares Expires 2023-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option to purchase 1,100 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 1,100 Old STERIS ordinary shares for $45.34 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 21:33 UTC |
Madsen JuliaSenior VP, Life Sciences
|
SaleOrdinary Shares | 800 | $192.55 | $154,040.00 |
DisclosureSEC source: 0001209191-20-057653 · doc4.xml · nonDerivative · entry 4 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,641 F2 · balance_after: 2,714 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 308 on June 1, 2021; 121 on June 1, 2021; 92 on June 1, 2021; 123 on June 1, 2021; 349 on October 1, 2021; 121 on May 31, 2022; 92 on May 31, 2022; 123 on June 1, 2022; 349 on October 3, 2022; 92 on May 31, 2023; 349 on October 2, 2023; 123 on June 1, 2023; 123 on June 3, 2024; and 349 on October 1, 2024. Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 21:33 UTC |
Madsen JuliaSenior VP, Life Sciences
|
SaleOrdinary Shares | 1,100 | $192.36 | $211,596.00 |
DisclosureSEC source: 0001209191-20-057653 · doc4.xml · nonDerivative · entry 3 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,441 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $192.0701 to $192.5460 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 21:33 UTC |
Madsen JuliaSenior VP, Life Sciences
|
Exercise / conversionOrdinary Shares | 800 | $53.52 | $42,816.00 |
DisclosureSEC source: 0001209191-20-057653 · doc4.xml · nonDerivative · entry 2 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,541 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 21:33 UTC |
Madsen JuliaSenior VP, Life Sciences
|
Exercise / conversionOrdinary Shares | 1,100 | $45.34 | $49,874.00 |
DisclosureSEC source: 0001209191-20-057653 · doc4.xml · nonDerivative · entry 1 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,741 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 21:35 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
SaleOrdinary Shares | 200 | $195.01 | $39,002.00 |
DisclosureSEC source: 0001209191-20-057654 · doc4.xml · nonDerivative · entry 3 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,405 F3 · balance_after: These 51,405 ordinary shares are held by the reporting person as trustee of a revocable trust established for his benefit. F4 · balance_after: 26,853 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,000 on June 1, 2021; 3,097 on June 1, 2021; 2,597 on June 1, 2021; 2,217 on June 1, 2021; 3,097 on May 31, 2022; 2,597 on May 31, 2022; 2,217 on June 1, 2022; 2,597 on May 31, 2023; 2,217 on June 1, 2023; and 2,217 on June 3, 2024. Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 21:35 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
SaleOrdinary Shares | 6,786 | $194.25 | $1,318,180.50 |
DisclosureSEC source: 0001209191-20-057654 · doc4.xml · nonDerivative · entry 2 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,605 F2 · price: Price reflects a weighted average sale price for multiple transactions ranging from $193.83 to $194.71 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 21:35 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
SaleOrdinary Shares | 3,014 | $193.02 | $581,762.28 |
DisclosureSEC source: 0001209191-20-057654 · doc4.xml · nonDerivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,391 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $192.66 to $193.64 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 06, 2020 Filed Nov 9, 2020 21:35 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
SaleOrdinary Shares | 1,300 | $182.19 | $236,847.00 |
DisclosureSEC source: 0001209191-20-057459 · doc4.xml · nonDerivative · entry 4 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,405 F3 · price: Price reflects a weighted average sale price for multiple transactions ranging from $182.03 to $182.49 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F4 · balance_after: These 61,405 ordinary shares are held by the reporting person as trustee of a revocable trust established for his benefit. F5 · balance_after: 26,853 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,000 on June 1, 2021; 3,097 on June 1, 2021; 2,597 on June 1, 2021; 2,217 on June 1, 2021; 3,097 on May 31, 2022; 2,597 on May 31, 2022; 2,217 on June 1, 2022; 2,597 on May 31, 2023; 2,217 on June 1, 2023; and 2,217 on June 3, 2024. Read SEC document |
| November 06, 2020 Filed Nov 9, 2020 21:35 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
SaleOrdinary Shares | 6,363 | $181.52 | $1,155,011.76 |
DisclosureSEC source: 0001209191-20-057459 · doc4.xml · nonDerivative · entry 3 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,705 F2 · price: Price reflects a weighted average sale price for multiple transactions ranging from $181.02 to $182.00 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 06, 2020 Filed Nov 9, 2020 21:35 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
SaleOrdinary Shares | 2,337 | $180.60 | $422,062.20 |
DisclosureSEC source: 0001209191-20-057459 · doc4.xml · nonDerivative · entry 2 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,068 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $179.98 to $180.97 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 05, 2020 Filed Nov 9, 2020 21:34 UTC |
Majors Cary LSr VP N America Com Operations
|
SaleOrdinary Shares | 2,000 | $180.00 | $360,000.00 |
DisclosureSEC source: 0001209191-20-057457 · doc4.xml · nonDerivative · entry 1 Majors Cary L · CIK 0001776271 · Sr VP N America Com Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,120 F1 · balance_after: 13,620 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 6,500 on June 1, 2021; 2,520 on May 31, 2022; 2,224 on May 31, 2023; and 2,376 on June 3, 2024. Read SEC document |
| November 05, 2020 Filed Nov 9, 2020 21:35 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
GiftOrdinary Shares | 4,897 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-057459 · doc4.xml · nonDerivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,405 Read SEC document |
| November 05, 2020 Filed Nov 9, 2020 21:32 UTC |
Burton Karen LVP, Controller & CAO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,852 | $0.00 Strike: $66.15 | $0.00 |
DisclosureSEC source: 0001209191-20-057455 · doc4.xml · derivative · entry 4 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,852 shares Expires 2025-05-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option to purchase 2,852 STERIS ordinary shares, which are fully vested, which was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 2,852 Old STERIS ordinary shares for $66.15 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| November 05, 2020 Filed Nov 9, 2020 21:32 UTC |
Burton Karen LVP, Controller & CAO
|
SaleOrdinary Shares | 1,750 | $179.48 | $314,090.00 |
DisclosureSEC source: 0001209191-20-057455 · doc4.xml · nonDerivative · entry 3 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,144 F2 · price: Price reflects a weighted average sale price for multiple transactions ranging from $179.40 to $179.70 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F3 · balance_after: 6,144 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,000 on June 1, 2021; 1,332 on May 31, 2022; 396 on June 1, 2022; 765 on May 31, 2022; 255 on May 31, 2023; 198 on June 1, 2023 and 198 on June 3, 2024. Read SEC document |
| November 05, 2020 Filed Nov 9, 2020 21:32 UTC |
Burton Karen LVP, Controller & CAO
|
SaleOrdinary Shares | 2,852 | $179.38 | $511,591.76 |
DisclosureSEC source: 0001209191-20-057455 · doc4.xml · nonDerivative · entry 2 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,894 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $179.05 to $179.78 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 05, 2020 Filed Nov 9, 2020 21:32 UTC |
Burton Karen LVP, Controller & CAO
|
Exercise / conversionOrdinary Shares | 2,852 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-057455 · doc4.xml · nonDerivative · entry 1 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,746 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 20:34 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 27,920 | $0.00 Strike: $53.52 | $0.00 |
DisclosureSEC source: 0001209191-20-054638 · doc4.xml · derivative · entry 9 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 27,920 shares Expires 2024-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: This option to purchase 28,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 28,000 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 20:34 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
SaleOrdinary Shares | 6,243 | $189.00 | $1,179,927.00 |
DisclosureSEC source: 0001209191-20-054638 · doc4.xml · nonDerivative · entry 6 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,522 F7 · shares: This exercise of stock options and sale of a total of 6,243 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on June 2, 2020. F8 · price: Price reflects a weighted average sale price for multiple transactions ranging from $188.6950 to $189.2850 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: 15,472 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 6,000 on June 1, 2021; 4,240 on May 31, 2022; 2,780 on May 31, 2023 and 2,452 on June 3, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.